Company: DMAC
Filing Date: 2025-08-01
Form Type: S-3
Source: 0001437749-25-024290
Chunk: 55

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-08-01
Form: S-3
Chunk 55
---
 July 21, 2025 (File No. 001-36291)) |
| 10.2    |     | Form of Registration Rights Agreement dated as of July 21, 2025 by and among DiaMedica Therapeutics Inc. and the Purchaser Party Thereto (incorporated by reference to Exhibit 10.2 to DiaMedica’s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 21, 2025 (File No. 001-36291))  |
| 23.1    |     | Consent of Baker Tilly US, LLP (filed herewith)                                                                                                                                                                                                                                                                         |
| 23.2    |     | Consent of Pushor Mitchell LLP (included in Exhibit 5.1)                                                                                                                                                                                                                                                                |
| 24.1    |     | Power of Attorney (included on signature page to the Registration Statement)                                                                                                                                                                                                                                            |
| 107     |     | Filing Fee Table (filed herewith)                                                                                                                                                                                                                                                                                       |

Item 17. Undertakings

(a) The undersigned registrant hereby undertakes:

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Filing Fee Tables” or “Calculation of Registration Fee” table, as applicable, in the effective registration statement; and

<div align='center'>39</div>

(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

provided, however, that paragraphs (